Solvias

Solvias is a leading global cGMP contract research organization (CRO) dedicated to guiding pharmaceutical companies through the complex landscape of drug development and commercialization. Established with a mission to provide extensive support for drug manufacturing and development, Solvias offers a comprehensive portfolio of analytical services designed to meet the diverse needs of the biopharmaceutical industry. The company's expertise encompasses a wide range of services including analytical method development, validation, drug substance and product testing, and comprehensive ADME/T testing.

The company prides itself on delivering high-quality results driven by an experienced team of over 800 professionals, including more than 175 PhD-level scientists. Located primarily in Europe and the U.S., Solvias serves over 700 customers worldwide, including 19 of the top 20 pharmaceutical companies. Their services are tailored to advance a biopharma company's path to commercialization by addressing challenges through innovative methodologies and advanced testing solutions for each phase of drug development. With an emphasis on collaboration and custom solutions, Solvias is committed to helping clients efficiently navigate the complexities of bringing their life-saving drugs to market while meeting stringent regulatory requirements.